POLITANO, Luisa
 Distribuzione geografica
Continente #
EU - Europa 17.218
NA - Nord America 8.858
AS - Asia 6.466
SA - Sud America 1.143
AF - Africa 88
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 33.794
Nazione #
RU - Federazione Russa 10.473
US - Stati Uniti d'America 8.728
SG - Singapore 2.468
IE - Irlanda 2.039
CN - Cina 1.316
HK - Hong Kong 1.205
UA - Ucraina 1.071
BR - Brasile 979
GB - Regno Unito 908
IT - Italia 620
DE - Germania 605
VN - Vietnam 602
FR - Francia 396
FI - Finlandia 352
SE - Svezia 321
TR - Turchia 232
GR - Grecia 178
IN - India 173
KR - Corea 146
JP - Giappone 78
AR - Argentina 68
CA - Canada 68
AT - Austria 57
BD - Bangladesh 56
ES - Italia 39
BE - Belgio 37
ID - Indonesia 36
MX - Messico 33
ZA - Sudafrica 33
NL - Olanda 32
EC - Ecuador 29
IQ - Iraq 23
CO - Colombia 20
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
PK - Pakistan 16
PL - Polonia 16
CH - Svizzera 11
MA - Marocco 11
PY - Paraguay 11
CL - Cile 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
PH - Filippine 9
PT - Portogallo 9
VE - Venezuela 9
EU - Europa 8
JM - Giamaica 8
HN - Honduras 7
KE - Kenya 7
KZ - Kazakistan 7
PE - Perù 7
SA - Arabia Saudita 7
JO - Giordania 6
LB - Libano 6
NP - Nepal 6
AU - Australia 5
ET - Etiopia 5
IL - Israele 5
LT - Lituania 5
NZ - Nuova Zelanda 5
RO - Romania 5
RS - Serbia 5
TH - Thailandia 5
TN - Tunisia 5
UY - Uruguay 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
IS - Islanda 4
KG - Kirghizistan 4
KW - Kuwait 4
OM - Oman 4
SC - Seychelles 4
AL - Albania 3
GE - Georgia 3
MY - Malesia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GA - Gabon 2
HR - Croazia 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
GT - Guatemala 1
Totale 33.775
Città #
Moscow 3.676
Dublin 2.037
Jacksonville 1.648
Hong Kong 1.198
Chandler 1.008
Singapore 998
Santa Clara 903
San Jose 550
Dallas 435
Princeton 316
Ashburn 301
Medford 248
Roxbury 195
Ho Chi Minh City 189
Ann Arbor 183
Boardman 181
Wilmington 148
Beijing 145
Seoul 144
Hefei 138
San Mateo 128
Woodbridge 127
Hanoi 117
Bengaluru 112
Bremen 111
Cambridge 90
Caserta 90
The Dalles 87
Helsinki 82
New York 72
São Paulo 71
Dong Ket 66
Des Moines 59
Mountain View 52
Düsseldorf 43
Houston 43
Munich 43
Los Angeles 40
Jinan 35
Nuremberg 32
Vienna 32
Da Nang 29
Guangzhou 29
Milan 29
Rome 29
Brussels 28
Nanjing 27
Rio de Janeiro 27
Haiphong 26
Norwalk 24
Auburn Hills 23
Frankfurt am Main 23
Orem 23
Tianjin 23
London 22
Redwood City 22
Belo Horizonte 21
Naples 21
Atlanta 19
Chicago 19
Hangzhou 19
Nanchang 18
Hebei 17
Memphis 17
Tashkent 17
Curitiba 16
Shenyang 16
West Jordan 16
Zhengzhou 16
Amsterdam 15
Johannesburg 15
Taiyuan 15
Chennai 14
Council Bluffs 14
Napoli 14
São José dos Campos 14
Toronto 14
Brasília 13
Haikou 13
Jakarta 13
Montreal 13
Porto Alegre 13
Santiago de Compostela 13
Tokyo 13
Warsaw 13
Boston 12
Buffalo 11
Changsha 11
Columbus 11
Guarulhos 11
Ottawa 11
Quito 11
Salvador 11
Shanghai 11
Venice 11
Asunción 10
Brooklyn 10
Campinas 10
Jiaxing 10
San Francisco 10
Totale 17.169
Nome #
1) Study of myocardial perfusion with Tl-201 in patients affected by Duchenne's/Becker's muscolar dystrophy 490
1) Comparison between SPECT myocardical scintigraphy with 201Tl and 99mTc-MIBI in patients affected by Duchenne's dystrophy 480
IperCKemia asintomatica. Quando e perchè fare l'indagine genetica 181
A report on 528 intragenic deletions detected in DMD and BMD patients by an Italian collaborative study 177
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 168
"I have got something positive out of this situation": psychological benefits of caregiving in relatives of young people with muscular dystrophy. 164
Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life. 164
The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients. 164
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 162
Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene 162
Autosomal dominant Ullrich congenital muscular dystrophy due to a de novo mutation in COL6A3 gene. A case report 159
A Unique Myopathy Syndrome in a Patient Disclosing Clinical, Laboratory, and Genetic Findings of Late-Onset Pompe Disease, Together with a Lack of Dysferlin on Muscle Biopsy 159
Novel small mutations along the DMD/BMD gene associated with different phenotypes 154
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 152
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 151
Identification of the Syrian hamster cardiomyopathy gene 149
Dispositivo per la valutazione del test del cammino dei 6 minuti 149
G.O.7 Multiple genetic variations in limb-girdle muscular dystrophies 149
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 148
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 148
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 147
Double carrier status in CANP3 and beta-sarcoglycan genes results in a mild disease phenotype 147
Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy 146
Alu-Mediated Insertions in the DMD Gene: A Difficult Puzzle to Interpret Clinically 146
Novel mutations in LMNA A/C gene and associated phenotypes 146
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 145
24 month longitudinal data in ambulant boys with D uchenne muscular dystrophy. 145
Aspetti clinici, genetici ed epidemiologici delleDistrofie muscolari dei Cingoli nel Sud Italia 145
Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein 144
Gene redundancies in the dystrophin-associated protein complex 143
P2.27 Full exome resequencing by next generation sequencing (NGS) combined with chip analysis for the genetic testing of unclassified myopathic patients 143
Cardiomyopathies associated with Muscular Dystrophies 141
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 141
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 140
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 140
A novel homozygous beta-sarcoglycan gene mutation: case description. 140
Analysis of caveolin-3 (CAV-3) gene in patients with limb-girdle muscular dystrophies and/or isolated hyperCKemia 140
Dystrophin gene scanning by DHPLC of DMD carriers without deletions or duplications 139
P.P.6 02 Cardiac and respiratory involvement in autosomal recessive limb-girdle muscular dystrophies 139
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 138
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 137
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 137
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 136
Acta Myologica (myopathies, cardiomyopathies and neuromyopathies) 136
6 Min walk test 12 month changes in DMD: correlation with the genotype 136
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 136
SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin function 135
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 134
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 134
Multiple heterozygosity for different muscle genes is not rare among individuals with pauci-symptomatic hyperCKemia 134
Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1 134
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies 132
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 131
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes 131
Evaluation of the cardiomyopathy in Becker muscular dystrophy 131
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 131
The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene 131
X-linked Emery-Dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample 129
X chromosome inactivation pattern in Duchenne muscular dystrophy carriers 129
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 129
Skewed X-chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy. 129
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 128
42nd ENMC Sponsored International Workshop: X-linked Cardiomyopathies 128
High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm 127
Burden, professional support, and social network in families of children and young adults with muscular dystrophies. 127
Advances in basic and clinical research in laminopathies. 127
Arrhythmic risk in Steinert Disease 127
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 127
Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene 127
The Role of TRPM4 Gene Mutations in Causing Familial Progressive Cardiac Conduction Disease: A Further Contribution 127
Bi-Allelic DES Gene Variants Causing Autosomal Recessive Myofibrillar Myopathies Affecting Both Skeletal Muscles and Cardiac Function 126
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 126
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 126
238th ENMC International Workshop: Updating management recommendations of cardiac dystrophinopathyHoofddorp, The Netherlands, 30 November - 2 December 2018. 126
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies 125
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on disease 124
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 124
Growth hormone deficiency in patients with Duchenne/Becker muscular dystrophy: association with dilated cardiomyopathy 124
Heart transplantation in a patient with Myotonic Dystrophy type 1 and end-stage dilated cardiomyopathy: A short term follow-up 123
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 123
A novel mutation in CPT2 gene in two unrelated patients from Campania region 123
Managing dystrophinopathic cardiomyopathy 123
G.P.4.03 Mutations in the lamin A/C gene: An emergent cause of fatal arrhythmias in congenital muscular dystrophies 123
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 122
Le Distrofie dei Cingoli autosomiche recessive: calpainopatie e disferlinopatie 121
Successful combined prenatal diagnosis for Duchenne and facio-scapulo- humeral dystrophies 121
[Serum isoenzymes in the diagnosis of some physiopathological conditions in the uterus] 121
Miocardiopatie e miopatie infiammatorie. 121
Dispositivo per la valutazione del test del "cammino dei sei minuti (six minutes walking test)" 121
Next generation sequencing applications are ready for genetic diagnosis of muscular dystrophies. 120
Stydy of anti Mullerian hormone levels in patients with myotonic dystrophy type 1. Prelilminary results. 120
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 119
The QT dispersion in the risk stratification of sudden death in Becker patients 119
Xp21 contiguous gene deletion syndrome presenting as Duchenne muscular dystrophy and glycerol kinase deficiency associated with intellectual disability: case report and review literature 119
Molecular and Muscle Pathology in a series of Caveolinopathy patients 118
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 118
Dysferlinopathy presenting as facio-scapulo-humeral dystrophy 118
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study 118
Il trattamento chirurgico delle scoliosi nella Distrofia Muscolare di Duchenne. 117
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy 116
Totale 14.267
Categoria #
all - tutte 120.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 0 0 137
2021/20221.919 138 14 32 44 701 11 22 50 57 159 143 548
2022/20233.815 366 98 25 318 390 296 21 214 1.893 26 77 91
2023/20241.332 114 59 60 128 526 51 13 25 8 20 90 238
2024/20254.168 21 24 44 93 606 437 547 367 620 873 312 224
2025/202616.729 533 673 1.046 886 1.346 9.765 744 382 711 340 217 86
Totale 34.200